Reported 12 months ago
Minister of Health and Welfare, Shih Chung-liang, refuted claims of factional struggles prompting the removal of Wu Hsiu-mei as the director of the Food and Drug Administration, stating it was due to the end of her temporary assignment, personal life planning, and the need to find better talents for the country's progress. The Minister emphasized a respectful approach to personnel arrangements, attributing them to natural progress. The appointment of the new FDA director, Chuan Sheng-hung, was also discussed as he nears retirement age, with the Minister highlighting difficulties in finding suitable replacements and mentioning plans for future improvements. Wu's removal sparked surprise and media speculation, countered by the Ministry's stance on seeking advancements and unity within the organization.
Source: YAHOO